Medicines, Poisons and Therapeutic Goods Amendment Regulation 2024 (No 1) (ACT)
Medicines, Poisons and Therapeutic Goods Amendment Regulation 2024 (No 1)
Subordinate Law SL2024-36
The Australian Capital Territory Executive makes the following regulation under the Medicines, Poisons and Therapeutic Goods Act 2008.
Dated 6 December 2024.
ANDREW BARR
Chief Minister
RACHEL STEPHEN-SMITH
Minister
Medicines, Poisons and Therapeutic Goods Amendment Regulation 2024 (No 1)
Subordinate Law SL2024-36
made under the
Medicines, Poisons and Therapeutic Goods Act 2008
Contents
Page
1 Name of regulation 1
2 Commencement 1
3 Legislation amended 1
4 Section 11 (2) (m) 1
5 Section 30 (2), definition of restricted medicine, paragraphs (c) and (d) 1
6 Section 41 (1) (d) 2
7 New section 121 (2A) 2
8 Section 125 (g) 2
9 Part 9.2 heading 3
10 Section 410 heading 3
11 Section 410 (1) 3
12 Section 635 (1) and (2) and note 3
13 Section 635 (3) (d) and (f) 4
14 Section 644 (2) (a) and (b) 4
15 Section 690 (1), definition of relevant dealing, paragraph (d) 4
16 New section 690 (3) and (4) 4
17 Dictionary, note 3 4
Name of regulation
This regulation is the Medicines, Poisons and Therapeutic Goods Amendment Regulation 2024 (No 1).
Commencement
(1)This regulation (other than sections 6 to 8) commences on the day after its notification day.
NoteThe naming and commencement provisions automatically commence on the notification day (see Legislation Act, s 75 (1)).
(2)Sections 6 to 8 commence 6 months after this regulation’s notification day.
Legislation amended
This regulation amends the Medicines, Poisons and Therapeutic Goods Regulation 2008.
Section 11 (2) (m)
after
adrenaline
insert
, naloxone
Section 30 (2), definition of restricted medicine, paragraphs (c) and (d)
substitute
(c)a monitored medicine.
Section 41 (1) (d)
after
name
insert
, date of birth
New section 121 (2A)
insert
(2A)Also, a pharmacist may dispense a prescription that does not comply with section 41 (1) if the reason it does not comply is because it does not include the date of birth or address of the person for whom the medicine is prescribed.
NoteThe dispensing pharmacist must ensure a written record is made of the name, date of birth and address of the person for whom the medicine is dispensed (see s 125 (g)).
Section 125 (g)
after
the name
insert
, date of birth
Part 9.2 heading
substitute
Part 9.2Emergency supply and administration of adrenaline, naloxone and salbutamol
Section 410 heading
substitute
Authorisations to supply and administer adrenaline, naloxone and salbutamol—Act, s 26 (1) (b) and s 37 (1) (b)
Section 410 (1)
after
adrenaline
insert
, naloxone
Section 635 (1) and (2) and note
substitute
(1)The medicines advisory committee consists of the members appointed by the director-general.
NoteFor laws about appointments, see the Legislation Act, pt 19.3.
(2)The director-general must appoint a chair of the medicines advisory committee from the members appointed under subsection (1).
(2A)A person, other than a person mentioned in subsection (3) (e), is eligible to be appointed as a member of the medicines advisory committee only if the person is a health practitioner.
Section 635 (3) (d) and (f)
before
1 member
insert
at least
Section 644 (2) (a) and (b)
substitute
(a)if the member (other than a member mentioned in section 635 (3) (e)) ceases to be a health practitioner; or
Section 690 (1), definition of relevant dealing, paragraph (d)
omit
New section 690 (3) and (4)
after the note, insert
(3)Also, the chief health officer may determine that a person is authorised for a relevant dealing with a dangerous poison mentioned in schedule 4, column 3.
(4)A determination is a disallowable instrument.
Dictionary, note 3
insert
· monitored medicine (see s 97A)
Endnotes
Notification
Notified under the Legislation Act on 12 December 2024.
Republications of amended laws
For the latest republication of amended laws, see align="center">© Australian Capital Territory 2024
0
0
0